April 16th 2025
The executive order targets lower drug prices through Medicare reforms, anticompetitive crackdowns, and transparency mandates.
Study Evaluates Impact of AE Severity on Health State Utility for CAR T Treatment in LBCL
February 9th 2022Health state utilities can be used to examine and compare the cost-effectiveness of the chimeric antigen receptor (CAR) T-cell therapies for large B-cell lymphoma (LBCL) as more become available.
Read More
A bipartisan congressional report estimates overdose deaths cost the United States $1 trillion yearly; 4 states announce plans to lift their statewide mask mandates for schools; study finds greater risk of pregnancy complications in expectant mothers with moderate COVID-19 symptoms.
Read More
Lymphoma Research Foundation CEO on Biden’s Cancer Moonshot, Financial Toxicity
February 3rd 2022On this episode of Managed Care Cast, we speak with Meghan Gutierrez, CEO of the Lymphoma Research Foundation, about financial toxicity, how the pandemic has affected patients’ financial needs when they have cancer, health care disparities and care gaps, and more.
Listen
What We're Reading: Infectious Omicron Subtype; Rise in Drug Prices; Alcohol Consumption and Cancer
January 31st 2022A novel Omicron subvariant, BA.2, was found to be 1.5 times more transmissible than the original Omicron strain; analysis finds drugmakers increased list prices by 6.6% at the beginning of the year; alcohol consumption linked with the development of several cancer types.
Read More
Steroid-Eluting Implants May Reduce Health Care Utilization From Chronic Rhinosinusitis
January 28th 2022Lower health care utilization was shown in patients with chronic rhinosinusitis, with and without nasal polyps, who had steroid-eluting implants vs those who did not in the 18 months following endoscopic sinus surgery.
Read More
Dupilumab Significantly Reduces Hospitalization Rates in Patients With Atopic Dermatitis
January 27th 2022Patients with atopic dermatitis (AD) treated with dupilumab showed reduced hospitalization rates and shorter duration of AD-related hospitalizations vs those treated with control therapies.
Read More
Number of Accountable Care Organizations Joining MSSP in 2022 Grew Slightly, CMS Says
January 26th 2022In its annual Medicare Shared Savings Program (MSSP) report, CMS said the number of accountable care organizations joining increased, but a trade group said the results should have been better.
Read More
The CDC is working to change its definition of being fully vaccinated against COVID-19; a study finds that men who tested positive for COVID-19 showed a short-term decline in fertility; a nonprofit group of scientists seeks to optimize the clinical trial process and reduce cost.
Read More
Israeli study finds the added antibody protection from a fourth COVID-19 vaccine dose is not enough to prevent Omicron infection; Texas abortion law remains in effect after appeals court ruling; insurer spending for the unproven COVID-19 drug ivermectin was estimated at $2.5 million for a week last summer.
Read More
Genomic Profiling for NSCLC Improves Survival Outcomes With Modest Budget Impact
January 14th 2022An increase in the use of comprehensive genomic profiling among patients with advanced non–small cell lung cancer (NSCLC) was associated with additional life-years gained and a low-cost budget impact.
Read More
Contributor: How Health Care Companies Can Use Upskilling to Navigate the Great Resignation
January 13th 2022The Great Resignation is sending health care workers out of the industry in massive numbers, and this, coupled with the ongoing transformation of health care, is creating the perfect storm. Alleviating their stress, burnout, and disengagement is a necessary first step. But the proper development, training, and upskilling is also crucial.
Read More
CMS Says It Will Limit Biogen’s AD Drug to Patients in Clinical Trials
January 11th 2022In a National Coverage Determination decision memo released Tuesday, CMS said it will gather public comment for 30 days about its plan to limit coverage for Alzheimer disease (AD) biologics that target plaque buildup in the brain to patients enrolled in certain clinical trials.
Read More
The Biden administration announced a requirement for insurance companies and group health plans to cover the cost of at-home COVID-19 tests; critical staffing shortages are reported nationwide amid record surges in COVID-19 cases and hospitalizations; the first-ever successful animal-to-human heart transplant was announced.
Read More
How Does CGP Testing Align With Recommendations, Impact Budgets?
January 10th 2022Posters from the Academy of Managed Care Pharmacy Nexus 2021 meeting detailed how coverage of genetic testing aligns with current guidelines as well as the potential budget impact of expanding access to comprehensive genomic profiling (CGP).
Read More